Bladder weakness can affect everything from exercise and long journeys to days out with friends, but it's not something that ...

AstraZeneca's Imfinzi combined with Pfizer's Padcev cut the risk of death in muscle-invasive bladder cancer patients by 42%, ...

The following is an article by ClaudeThe story of how I made 3 games to flush out ureter stones while suffering from ureter ...

The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.

Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy ...

Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...

"As a 38 year old mum of 2 who has struggled for years with stress incontinence due to childbirth. I have finally found my ...

Learn about types of incontinence pads for MS, differences between bladder and menstrual pads, skin protection tips, insurance coverage, and when to seek medical help.

ERBB2-positive bladder cancer showed a 73.1% complete response rate with combination therapy in a phase II trial.

In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...

Bladder weakness is commonly linked with getting older, but it's a condition that can affect younger women as well. For those ...

ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced completion of the database lock for Cohort A of QUILT-2.005 (NCT02138734), its randomized, controlled, registrational trial ...